Offerings are only beginning to come to market after a very tough year in 2022. And September and October to date haven't offered much to give an investor hints of the values in newly-public companies.Cava is up 50.6% from its June pricing of $22, but is down 43% from its August intraday high of $58.10.ARM is down less than 1% from its $51 pricing on Sept. 13. Klaviyo is up 5% from its pricing but 15.6% from its top.
What has stalled the IPO market this time starts with the the hangover from wild speculation in 2020 and 2021. That makes the IPO market deeply vulnerable because into 2021, companies that could show massive revenue growth, regardless of profitability, could easily sell their shares and pay very low rates for money.